Skip to main content
SEBI CSCRF · Intermediaries

SEBI CSCRF for Research Analysts

For Research Analysts, 1 tiers are reachable, decided by are you registered with SEBI in another category.

Non-registered RAs → exempt (SaaS declaration only). Institutional RAs in another category → tier of that other category. Reporting to BSE Ltd.

Classification

What decides the tier for a Research Analyst

Research Analysts follow the same shape as non-individual advisers: a standalone registration falls outside the framework, and a second SEBI registration pulls the firm into whatever that category attracts. Supervision and reporting for analysts moved to the same administering body that oversees advisers, which is a change from where the master circular originally sent them. A firm following the original text alone would file to the wrong place.

Are you registered with SEBI in another category?

Some answers put a Research Analyst outside CSCRF entirely. The wizard states the exact threshold and shows the exemption alongside the result.

Obligations

What the Small-size tier requires

Only the tiers a Research Analyst can land in are listed.

Small-size REs

Stock Brokers 10k-1L clients OR ₹10k-1L Cr volume, AMCs <₹10k Cr AUM, Custodians <₹1L Cr AUC, Portfolio Managers ₹3k-10k Cr AUM, AIF+VCF managers ₹3k-10k Cr corpus, RTAs 10k-1Cr folios, all active Merchant Bankers, Non-individual IAs (registered in another category).

VAPT

Once a year

Cyber audit

Once a year (twice a year if providing IBT or Algo trading)

Drill

Annually

  • Onboard to Market SOC (NSE/BSE): MANDATORY, unless RE has own SOC and submits efficacy reports
  • Designated CISO or equivalent officer
  • IT Committee optional (otherwise MD/CEO/Board approves CSCRF compliance)
  • Annual cyber resilience posture evaluation

M-SOC

Market SOC mandatory unless you run your own

HSM for key storage

Risk-assessed alternative permitted

CISO reporting line

Designated officer is sufficient

IT Committee

Not mandated

RTO

As set in your CCMP

RPO

As set in your CCMP

Incident reporting

6 hr to SEBI Incident Reporting portal + [email protected] AND CERT-In (per April 2022 Directions). Interim report 3d, mitigation 7d, RCA 30d, incident-VAPT 45d (CSCRF Annexure-O).

Scope

What a CSCRF VAPT has to reach at a Research Analyst

Unpublished research is price-sensitive for exactly as long as it is unpublished, and the window is where the exposure lives. Early access to a rating or target change is tradeable, whether it comes through a distribution list, a shared drafting folder, or a staging site that is reachable before release. The reputational failure mode is the mirror image: published research altered or impersonated after the fact.

Cyber audit covers 100% of critical systems and a 25% sample of the rest, so what you classify as critical decides how much of the estate gets tested.

The estate is small and the sensitive part of it is the publication path:

  • The research authoring, review and publication platform
  • Distribution lists and the mechanism that releases a report to them
  • Embargo handling between a report being finalised and being published
  • Client and subscriber records
  • The public website or application carrying published research
  • Systems belonging to any other registered activity, which is what determines the tier

Where this goes wrong

The staging environment is the leak

Research is commonly staged before release on infrastructure that is reachable, indexable or predictably named, and treated as internal because nobody links to it. Predictable URLs and unauthenticated preview paths are the recurring finding here, and they defeat every control applied to the release process itself.

Submission

Where a Research Analyst files, and by when

Reports go to BSE Ltd. The Apr 2025 clarification (CIR/2025/60 §2.4.1) moved Investment Advisers and Research Analysts to BSE Ltd as reporting authority, from BASL and SEBI respectively.

Within 1 month

Report submitted

The VAPT report is filed within a month of the activity completing, after your IT Committee has approved it where one is mandated, together with the MD/CEO declaration the format requires.

Within 3 months

Findings closed

Closure runs from submission, graded by criticality. Anything still open at three months needs IT Committee approval to stay open and has to be closed before the next cycle starts.

Within 5 months

Revalidation complete

Revalidation runs from completion of the VAPT, not from submission, so a cycle started late in the year rarely leaves room to finish it.

Plan the cycle at the start of the financial year, not backwards from the deadline. No audit period may be left unaudited because a category changed mid-year: an unaudited stretch has to be pulled into the current cycle.

How we help

CERT-In empanelled, and the report is written for the submission

We run the VAPT and cyber-audit scope your tier requires, and the report is mapped to the CSCRF control set so it can be filed as written.

Verified against the source circulars as of 3 August 2026.

FAQ

Common questions

These are the questions we are asked most often about this category.

Talk to our team
Does SEBI CSCRF apply to Research Analysts?+
Yes. Research Analysts fall under CSCRF, unless they are below the threshold set out below, in which case they are excluded entirely. For Research Analysts, 1 tiers are reachable, decided by are you registered with SEBI in another category.
How often does a Research Analyst need VAPT under CSCRF?+
At the Small-size tier: Once a year. Cyber audit: Once a year (twice a year if providing IBT or Algo trading).
Where does a Research Analyst submit its CSCRF reports?+
To BSE Ltd. The Apr 2025 clarification (CIR/2025/60 §2.4.1) moved Investment Advisers and Research Analysts to BSE Ltd as reporting authority, from BASL and SEBI respectively.
Which SEBI circular sets this out?+
As per SEBI/HO/ITD-1/ITD_CSC_EXT/P/CIR/2024/113 dated 20-Aug-2024 read with CIR/2024/184, CIR/2025/45, CIR/2025/60, CIR/2025/96, CIR/2025/119, the SEBI FAQ (11-Jun-2025), and the May 2026 AI Vulnerability Detection Advisory HO/13/19/12(1)2026-ITD-1_CIMGI/10873/2026.